InflaRx NV buy Lifesci Capital
Start price
05.04.23
/
50%
€5.34
Target price
05.04.24
-
Performance (%)
-73.58%
End price
06.04.24
€1.41
Summary
This prediction ended on 06.04.24 with a price of €1.41. The BUY prediction by Lifesci_Capital for InflaRx NV performed very badly with a performance of -73.58%. Lifesci_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| InflaRx NV | 10.777% | 10.777% | 143.862% | -44.403% |
| iShares Core DAX® | 0.437% | 5.897% | 8.047% | 65.579% |
| iShares Nasdaq 100 | 1.057% | 0.920% | 28.466% | 90.185% |
| iShares Nikkei 225® | 1.769% | 1.228% | 47.574% | 84.991% |
| iShares S&P 500 | 0.368% | 1.920% | 23.200% | 70.760% |
Comments by Lifesci_Capital for this prediction
In the thread InflaRx NV diskutieren
InflaRx (NASDAQ: IFRX) was upgraded by analysts at Lifesci Capital from a "market perform" rating to an "outperform" rating.
Ratings data for IFRX provided by MarketBeat
In the thread Trading InflaRx NV
Die von Lifesci_Capital gewählte maximale Laufzeit wurde überschritten